α-T-catenin is expressed in human brain and interacts with the Wnt signaling pathway but is not responsible for linkage to chromosome 10 in Alzheimer’s disease

被引:0
|
作者
Victoria Busby
Steven Goossens
Petra Nowotny
Gillian Hamilton
Scott Smemo
Denise Harold
Dragana Turic
Luke Jehu
Amanda Myers
Meredith Womick
Daniel Woo
Danielle Compton
Lisa M. Doil
Kristina M. Tacey
Kit F. Lau
Safa Al-Saraj
Richard Killick
Stuart Pickering-Brown
Pamela Moore
Paul Hollingworth
Nicola Archer
Catherine Foy
Sarah Walter
Corrine Lendon
Takeshi Iwatsubo
John C. Morris
Joanne Norton
David Mann
Barbara Janssens
John Hardy
Michael O’Donovan
Lesley Jones
Julie Williams
Peter Holmans
Michael J. Owen
Andrew Grupe
John Powell
Jolanda van Hengel
Alison Goate
Frans Van Roy
Simon Lovestone
机构
[1] Institute of Psychiatry,Department of Neuroscience
[2] Ghent University,Molecular Cell Biology Unit, Department for Molecular Biomedical Research, Flanders Interuniversity Institute for Biotechnology (VIB)
[3] Washington University School of Medicine,Departments of Psychiatry, Neurology and Genetics
[4] University of Wales College of Medicine,Department of Psychological Medicine
[5] National Institutes of Health,Laboratory of Neurogenetics, National Institute on Aging
[6] Queen Elizabeth Psychiatric Hospital,Department of Psychiatry, University of Birmingham
[7] University of Tokyo,Department of Neuropathology and Neuroscience, Graduate School of Pharmaceutical Sciences
[8] Hope Hospital,Greater Manchester Neurosciences Centre
[9] Institute of Public Health,MRC Biostatistics Unit
[10] Celera Diagnostics,undefined
来源
NeuroMolecular Medicine | 2004年 / 5卷
关键词
CTNNA3; α-T-catenin; Alzheimer’s disease; chromosome 10; amyloid; Aβ; age of onset; APOE; Wn;
D O I
暂无
中图分类号
学科分类号
摘要
The gene encoding α-T-catenin, CTNNA3, is positioned within a region on chromosome 10, showing strong evidence of linkage to Alzheimer’s disease (AD), and is therefore a good positional candidate gene for this disorder. We have demonstrated that α-T-catenin is expressed in human brain, and like other α-catenins, it inhibits Wnt signaling and is therefore also a functional candidate. We initially genotyped two single-nucleotide polymorphisms (SNPs) in the gene, in four independent samples comprising over 1200 cases and controls but failed to detect an association with either SNP. Similarly, we found no evidence for association between CTNNA3 and AD in a sample of subjects showing linkage to chromosome 10, nor were these SNPs associated with Aβ deposition in brain. To comprehensively screen the gene, we genotyped 30 additional SNPs in a subset of the cases and controls (n>700). None of these SNPs was associated with disease. Although an excellent candidate, we conclude that CTNNA3 is unlikely to account for the AD susceptibility locus on chromosome 10.
引用
收藏
页码:133 / 146
页数:13
相关论文
共 50 条
  • [1] α-T-catenin is expressed in human brain and interacts with the Wnt signaling pathway but is not responsible for linkage to chromosome 10 in Alzheimer's disease
    Busby, V
    Goossens, S
    Nowotny, P
    Hamilton, G
    Smemo, S
    Harold, D
    Turic, D
    Jehu, L
    Myers, A
    Womick, M
    Woo, D
    Compton, D
    Doil, LM
    Tacey, KM
    Lau, KF
    Al-Saraj, S
    Killick, R
    Pickering-Brown, S
    Moore, P
    Hollingworth, P
    Archer, N
    Foy, C
    Walter, S
    Lendon, C
    Iwatsubo, T
    Morris, JC
    Norton, J
    Mann, D
    Janssens, B
    Hardy, J
    O'Donovan, M
    Jones, L
    Williams, J
    Holmans, P
    Owen, MJ
    Grupe, A
    Powell, J
    van Hengel, J
    Goate, A
    Van Roy, F
    Lovestone, S
    NEUROMOLECULAR MEDICINE, 2004, 5 (02) : 133 - 146
  • [2] Wnt/β-Catenin Signaling in Alzheimer's Disease
    De Ferrari, Giancarlo V.
    Avila, Miguel E.
    Medina, Matias A.
    Perez-Palma, Eduardo
    Bustos, Bernabe I.
    Alarcon, Marcelo A.
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2014, 13 (05) : 745 - 754
  • [3] Icariin ameliorates glycolytic dysfunction in Alzheimer's disease models by activating the Wnt/β-catenin signaling pathway
    Liu, Ju
    Wei, Ai-Hong
    Liu, Ting-Ting
    Ji, Xin-Hao
    Zhang, Ying
    Yan, Fei
    Chen, Mei-Xiang
    Hu, Jin-Bo
    Zhou, Shao-Yu
    Shi, Jing-Shan
    Jin, Hai
    Jin, Feng
    FEBS JOURNAL, 2024, 291 (10) : 2221 - 2241
  • [4] Dysfunctional Wnt/β-catenin signaling contributes to blood-brain barrier breakdown in Alzheimer's disease
    Liu, Lumei
    Wan, Wenbin
    Xia, Shijin
    Kalionis, Bill
    Li, Yaming
    NEUROCHEMISTRY INTERNATIONAL, 2014, 75 : 19 - 25
  • [5] Activation of Wnt/β-catenin pathway mitigates blood-brain barrier dysfunction in Alzheimer's disease
    Wang, Qi
    Huang, Xiaomin
    Su, Yixun
    Yin, Guowei
    Wang, Shouyu
    Yu, Bin
    Li, Hui
    Qi, Junhua
    Chen, Hui
    Zeng, Wen
    Zhang, Kai
    Verkhratsky, Alexei
    Niu, Jianqin
    Yi, Chenju
    BRAIN, 2022, 145 (12) : 4474 - 4488
  • [6] HIV's Nef Interacts with β-Catenin of the Wnt Signaling Pathway in HEK293 Cells
    Weiser, Keren
    Barton, Meredith
    Gershoony, Dafna
    DasGupta, Ramanuj
    Cardozo, Timothy
    PLOS ONE, 2013, 8 (10):
  • [7] Riluzole: a therapeutic strategy in Alzheimer's disease by targeting the WNT/β-catenin pathway
    Vallee, Alexandre
    Vallee, Jean-Noel
    Guillevin, Remy
    Lecarpentier, Yves
    AGING-US, 2020, 12 (03): : 3095 - 3113
  • [8] Restoring Wnt/β-catenin signaling is a promising therapeutic strategy for Alzheimer's disease
    Jia, Lin
    Pina-Crespo, Juan
    Li, Yonghe
    MOLECULAR BRAIN, 2019, 12 (01)
  • [9] WNT/β-catenin Pathway: a Possible Link Between Hypertension and Alzheimer's Disease
    Vallee, Alexandre
    Vallee, Jean-Noel
    Lecarpentier, Yves
    CURRENT HYPERTENSION REPORTS, 2022, 24 (10) : 465 - 475
  • [10] WNT/β-catenin Pathway: a Possible Link Between Hypertension and Alzheimer’s Disease
    Alexandre Vallée
    Jean-Noël Vallée
    Yves Lecarpentier
    Current Hypertension Reports, 2022, 24 : 465 - 475